Vedran Radojcic

8PUBLICATIONS
25CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.

Daniel Wolff, Corey Cutler, Stephanie J Lee

|Dec 02, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.

Carrie L Kitko, Mukta Arora, Zachariah DeFilipp

|Oct 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.

Shannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai

|Feb 03, 2021
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.

Wei Jia, Jonathan C Poe, Hsuan Su

|Jun 12, 2019
Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease.

Jooho Chung, Vedran Radojcic, Eric Perkey

Pageof 2

Frequent Collaborators

2 joint publications

Bruce R Blazar

1 joint publications

Timothy J Parnell

1 joint publications

Nathalie Labrecque

1 joint publications

Todd V Brennan